These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

386 related articles for article (PubMed ID: 18524979)

  • 21. Microsomal prostaglandin E synthase-1 inhibition in cardiovascular inflammatory disease.
    Wang M; Song WL; Cheng Y; Fitzgerald GA
    J Intern Med; 2008 May; 263(5):500-5. PubMed ID: 18410593
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of microsomal prostaglandin E synthase-1 by aminothiazoles decreases prostaglandin E2 synthesis in vitro and ameliorates experimental periodontitis in vivo.
    Kats A; Båge T; Georgsson P; Jönsson J; Quezada HC; Gustafsson A; Jansson L; Lindberg C; Näsström K; Yucel-Lindberg T
    FASEB J; 2013 Jun; 27(6):2328-41. PubMed ID: 23447581
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Potent inhibition of human 5-lipoxygenase and microsomal prostaglandin E₂ synthase-1 by the anti-carcinogenic and anti-inflammatory agent embelin.
    Schaible AM; Traber H; Temml V; Noha SM; Filosa R; Peduto A; Weinigel C; Barz D; Schuster D; Werz O
    Biochem Pharmacol; 2013 Aug; 86(4):476-86. PubMed ID: 23623753
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biochemical and pharmacological profile of a tetrasubstituted furanone as a highly selective COX-2 inhibitor.
    Riendeau D; Percival MD; Boyce S; Brideau C; Charleson S; Cromlish W; Ethier D; Evans J; Falgueyret JP; Ford-Hutchinson AW; Gordon R; Greig G; Gresser M; Guay J; Kargman S; Léger S; Mancini JA; O'Neill G; Ouellet M; Rodger IW; Thérien M; Wang Z; Webb JK; Wong E; Chan CC
    Br J Pharmacol; 1997 May; 121(1):105-17. PubMed ID: 9146894
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lipopolysaccharide-induced expression of microsomal prostaglandin E synthase-1 mediates late-phase PGE2 production in bone marrow derived macrophages.
    Xiao L; Ornatowska M; Zhao G; Cao H; Yu R; Deng J; Li Y; Zhao Q; Sadikot RT; Christman JW
    PLoS One; 2012; 7(11):e50244. PubMed ID: 23226252
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Discovery of disubstituted phenanthrene imidazoles as potent, selective and orally active mPGES-1 inhibitors.
    Giroux A; Boulet L; Brideau C; Chau A; Claveau D; Côté B; Ethier D; Frenette R; Gagnon M; Guay J; Guiral S; Mancini J; Martins E; Massé F; Méthot N; Riendeau D; Rubin J; Xu D; Yu H; Ducharme Y; Friesen RW
    Bioorg Med Chem Lett; 2009 Oct; 19(20):5837-41. PubMed ID: 19748780
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regulation of the microsomal prostaglandin E synthase-1 in polarized mononuclear phagocytes and its constitutive expression in neutrophils.
    Mosca M; Polentarutti N; Mangano G; Apicella C; Doni A; Mancini F; De Bortoli M; Coletta I; Polenzani L; Santoni G; Sironi M; Vecchi A; Mantovani A
    J Leukoc Biol; 2007 Aug; 82(2):320-6. PubMed ID: 17505022
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Microglia-specific expression of microsomal prostaglandin E2 synthase-1 contributes to lipopolysaccharide-induced prostaglandin E2 production.
    Ikeda-Matsuo Y; Ikegaya Y; Matsuki N; Uematsu S; Akira S; Sasaki Y
    J Neurochem; 2005 Sep; 94(6):1546-58. PubMed ID: 16000148
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regulation of gene expression by MF63, a selective inhibitor of microsomal PGE synthase 1 (mPGES1) in human osteoarthritic chondrocytes.
    Tuure L; Pemmari A; Hämäläinen M; Moilanen T; Moilanen E
    Br J Pharmacol; 2020 Sep; 177(18):4134-4146. PubMed ID: 32449517
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Selective inducible microsomal prostaglandin E(2) synthase-1 (mPGES-1) inhibitors derived from an oxicam template.
    Wang J; Limburg D; Carter J; Mbalaviele G; Gierse J; Vazquez M
    Bioorg Med Chem Lett; 2010 Mar; 20(5):1604-9. PubMed ID: 20144869
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structure-activity relationship of nonacidic quinazolinone inhibitors of human microsomal prostaglandin synthase 1 (mPGES 1).
    Rörsch F; Buscató E; Deckmann K; Schneider G; Schubert-Zsilavecz M; Geisslinger G; Proschak E; Grösch S
    J Med Chem; 2012 Apr; 55(8):3792-803. PubMed ID: 22449023
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Discovery of benzo[g]indol-3-carboxylates as potent inhibitors of microsomal prostaglandin E(2) synthase-1.
    Koeberle A; Haberl EM; Rossi A; Pergola C; Dehm F; Northoff H; Troschuetz R; Sautebin L; Werz O
    Bioorg Med Chem; 2009 Dec; 17(23):7924-32. PubMed ID: 19884011
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Discovery and Characterization of 2-Acylaminoimidazole Microsomal Prostaglandin E Synthase-1 Inhibitors.
    Schiffler MA; Antonysamy S; Bhattachar SN; Campanale KM; Chandrasekhar S; Condon B; Desai PV; Fisher MJ; Groshong C; Harvey A; Hickey MJ; Hughes NE; Jones SA; Kim EJ; Kuklish SL; Luz JG; Norman BH; Rathmell RE; Rizzo JR; Seng TW; Thibodeaux SJ; Woods TA; York JS; Yu XP
    J Med Chem; 2016 Jan; 59(1):194-205. PubMed ID: 26653180
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Liver X receptor ligands inhibit the lipopolysaccharide-induced expression of microsomal prostaglandin E synthase-1 and diminish prostaglandin E2 production in murine peritoneal macrophages.
    Ninomiya Y; Yasuda T; Kawamoto M; Yuge O; Okazaki Y
    J Steroid Biochem Mol Biol; 2007 Jan; 103(1):44-50. PubMed ID: 17049841
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Microsomal prostaglandin E synthase-1 enhances bone cancer growth and bone cancer-related pain behaviors in mice.
    Isono M; Suzuki T; Hosono K; Hayashi I; Sakagami H; Uematsu S; Akira S; DeClerck YA; Okamoto H; Majima M
    Life Sci; 2011 Apr; 88(15-16):693-700. PubMed ID: 21324324
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Perspective of microsomal prostaglandin E2 synthase-1 as drug target in inflammation-related disorders.
    Koeberle A; Werz O
    Biochem Pharmacol; 2015 Nov; 98(1):1-15. PubMed ID: 26123522
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Deletion of microsomal prostaglandin E2 (PGE2) synthase-1 reduces inducible and basal PGE2 production and alters the gastric prostanoid profile.
    Boulet L; Ouellet M; Bateman KP; Ethier D; Percival MD; Riendeau D; Mancini JA; Méthot N
    J Biol Chem; 2004 May; 279(22):23229-37. PubMed ID: 15016822
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Microsomal prostaglandin E synthase-1 aggravates inflammation and demyelination in a mouse model of multiple sclerosis.
    Takeuchi C; Matsumoto Y; Kohyama K; Uematsu S; Akira S; Yamagata K; Takemiya T
    Neurochem Int; 2013 Feb; 62(3):271-80. PubMed ID: 23266396
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cyclooxygenase-2, not microsomal prostaglandin E synthase-1, is the mechanism for interleukin-1β-induced prostaglandin E2 production and inhibition of insulin secretion in pancreatic islets.
    Parazzoli S; Harmon JS; Vallerie SN; Zhang T; Zhou H; Robertson RP
    J Biol Chem; 2012 Sep; 287(38):32246-53. PubMed ID: 22822059
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alleviating CYP and hERG liabilities by structure optimization of dihydrofuran-fused tricyclic benzo[d]imidazole series - Potent, selective and orally efficacious microsomal prostaglandin E synthase-1 (mPGES-1) inhibitors: Part-2.
    Muthukaman N; Deshmukh S; Tambe M; Pisal D; Tondlekar S; Shaikh M; Sarode N; Kattige VG; Sawant P; Pisat M; Karande V; Honnegowda S; Kulkarni A; Behera D; Jadhav SB; Sangana RR; Gudi GS; Khairatkar-Joshi N; Gharat LA
    Bioorg Med Chem Lett; 2018 Apr; 28(7):1211-1218. PubMed ID: 29519738
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.